Questo articolo ripercorre un caso clinico di un uomo di 83 anni in trattamento con monoscambio diurno (soluzione isotonica 1.36%, 2 L). Ad ottobre 2019 il paziente veniva ricoverato per dispnea e riduzione dell’ultrafiltrazione peritoneale con riscontro radiologico di versamento pleurico destro. Si eseguiva quindi una TC peritoneo-pleurica basale e un’altra dopo 4 ore di stazionamento di 2 L di soluzione isotonica con 100 ml di mezzo di contrasto. La seconda evidenziava una comunicazione peritoneo-pleurica. Si decideva allora di eseguire una videotoracoscopia (VATS) che non evidenziava soluzioni di continuo diaframmatiche. Si eseguiva quindi una pleurodesi con 8 gr di talco sterile. Il paziente veniva dimesso nella terza giornata, in terapia conservativa e in dieta ipoproteica. Dopo due settimane, si procedeva a nuova TC peritoneo-pleurica che non evidenziava più alcun passaggio di liquido di contrasto nella cavità toracica.
Per quanto riguarda il trattamento della comunicazione peritoneo-pleurica, la toracoscopia permette sia la riparazione con patch di eventuale difetto diaframmatico sia di attuare la pleurodesi chimica con agenti irritanti. Nella nostra esperienza la toracoscopia ha permesso di attuare una pleurodesi accurata che ha consentito, dopo solo due settimane di trattamento conservativo, di riprendere la DP.
Pleuro-peritoneal leakage is an uncommon complication of peritoneal dialysis (PD) with an incidence of 1.6%. It occurs in higher frequency in female patients and in the right hemithorax (90% of cases). He was affected by end stage renal disease in single kidney (previous nephrectomy due to renal neoplasia in 2017), atrial fibrillation, arterial hypertension and benign prostatic hyperplasia. In October 2019, the patient was hospitalized due to dyspnea and reduction of peritoneal ultrafiltration. At chest X-ray a right pleural leakage was evidenced. In the assumption of a pleuro-peritoneal connection, CAPD was suspended and the patient was treated with furosemide iv, obtaining the complete resolution of the pleural leakage. The patient, informed about the risks of potential relapse resuming PD, rejected to shift to haemodialysis.

Fig. CAPD was again suspended and it was performed a pleuro-peritoneal CT scan. A basic CT scan excluded pleural leakage (Figure 2A). It was then injected an isotonic solution (2000ml) with 100ml of contrast medium (Gastrografin®). The second CT scan, performed after 4 hours, evidenced an hyperdense peritoneal leakage and a right pleural leakage, due to pleuro-peritoneal connection. It was unlikely identifiable, due to small dimension, the diaphragm connection. Considering the concern of the patient to not shift to haemodialysis, it was decided to perform a video-assisted thoracoscopic surgery (VATS). After evaluation with echocardiography and spirometry test, and after written consensus from the patient, VATS was performed in general anesthesia. It was done an initial access from the 7th right inter-costal space, with the introduction of the optical device, evidencing a free pulmonary cavity. It was then performed an ulterior access from the 6th inter-costal space, followed by a detailed exploration of the pleural cavity, especially of the diaphragm’s surface, not evidencing any connection with the abdomen. It was executed a pleurodesis using 8gr of sterile talcum covering diaphragm’s surface. The surgical procedure lasted 10 minutes without complications. After two weeks, a new pleuro-peritoneal CT scan was executed. After basic thorax scan, it was injected an isotonic solution (2000 ml) with 100 ml of contrast medium.
We presented a case of a right pleural effusion in pleuro-peritoneal leakage of diaphragmatic type. Hydrothorax is a complication related to PD, caused by a pleural-peritoneal fistula (congenital or acquired) which allows the passage in the pleural cavity of the peritoneal liquid. In 50% of PD patients it is necessary to shift to haemodialysis. There are no clear guidelines concerning the treatment of the pleuro-peritoneal communication. It can be of conservative type (reduction of the dialytic-exchange volumes and the temporary PD suspension) or surgical type. The procedure of pleurodesis leads the intra-pleural injection of agents like autologous blood, sterile talc or fibrine glue, through the drain tube. The mini-invasive surgery procedure using an optical device for the treatment of the pleuro-peritoneal fistula was first described in 1996. When no defect of the diaphragm is evidenced, it is advised to use the chemical pleurodesis technique with sterile talc, that has a reported success rate close to 70%. The mass of talc adopted varies from 2.5g to 8g and is not correlated to the success of the procedure. CAPD can be resumed from 1 to 7 weeks after the surgery. In conclusion, VATS with plural-injection of talc demonstrated its safety and efficiency in the treatment of pleuro-peritoneal leakage in a patient motivated in carrying on PD. Indeed, the conservative treatment is characterized by an elevated percentage of failure with permanent shift to haemodialysis, while VATS allows both the patch-reparation of the eventual diaphragm’s defect and the chemical pleurodesis with the instillation of irritating agents in the pleural cavity through the drain line. In our experience, VATS permitted, after excluding macro diaphragm’s defects, an efficient chemical pleurodesis, with mini-invasive approach, instilling talc in the whole pleural cavity, particularly at diaphragm’s level.
In our case, the patient resumed peritoneal dialysis after approximately one month from the intervention. The diaphragmatic defect was addressed via patch placement and talc pleurodesis, achieving restoration of peritoneal ultrafiltration. The overall outcome supports the role of VATS as a safe and effective option to manage pleuro-peritoneal leakage in PD patients who wish to continue PD, avoiding immediate shift to haemodialysis in selected cases.
tags: #dialisi #peritoneale #versamento #pleurico